{
    "clinical_study": {
        "@rank": "41688", 
        "arm_group": [
            {
                "arm_group_label": "pramipexole", 
                "arm_group_type": "Experimental", 
                "description": "dosage form: tablet dosage: pramipexole 0.125/0.25/0.5/1mg frequency: tid duration: 24weeks"
            }, 
            {
                "arm_group_label": "Bromocriptine", 
                "arm_group_type": "Active Comparator", 
                "description": "bromocriptine dosage form: white round tablet"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether pramipexole and bromocriptine are\n      effective in the treatment of non-motor symptoms in Parkinson's Disease."
        }, 
        "brief_title": "Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVE Evaluate the Improvement of Nonmotor symptom scale (NMSS) between\n      Pramipexole and Bromocriptine for early Parkinson's disease during 24-week treatment\n\n      SECONDARY OBJECTIVE\n\n        -  Evaluate the improvement for Depression which is one of the Nonmotor symptoms\n\n        -  Evaluate the improvement of clinical symptoms between two groups\n\n        -  Evaluate the improvement of Quality of Life  between two groups"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Parkinson's disease patients in accordance with UK Queensquare Brain Bank\n\n          -  modified Hoehn & Yahr stage <3\n\n          -  Dopamine agents(Levodopa, dopamine agonists) naive patients, or the patients who have\n             discontinued the agents at least four weeks before the screening in case of using the\n             dopamine agents are administered before.\n\n        Exclusion Criteria:\n\n          -  K-MMSE<24\n\n          -  History of drug-induced Parkinsonism\n\n          -  secondary parkinsonism\n\n          -  History of schizophrenia or hallucination\n\n          -  Requirement of treatment with anti-depressants due to depressive disorder\n\n          -  Pregnant and/or breeding women\n\n          -  Renal inadequacy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01673724", 
            "org_study_id": "SKL001"
        }, 
        "intervention": [
            {
                "arm_group_label": "pramipexole", 
                "description": "pramipexole", 
                "intervention_name": "pramipexole", 
                "intervention_type": "Drug", 
                "other_name": "Sandoz Pramipexole"
            }, 
            {
                "arm_group_label": "Bromocriptine", 
                "description": "bromocriptine", 
                "intervention_name": "Bromocriptine", 
                "intervention_type": "Drug", 
                "other_name": "Parlodel tab"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bromocriptine", 
                "Pramipexol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 3, 2012", 
        "location": [
            {
                "contact": {
                    "last_name": "na"
                }, 
                "facility": {
                    "address": {
                        "city": "Ansan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Korea University Ansan Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "na"
                }, 
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Inje University Busan Paik Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "na"
                }, 
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Youngnam University Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "na"
                }, 
                "facility": {
                    "address": {
                        "city": "Kangwon", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Kangwon Nat'l University Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "na"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Korea University Anam Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "na"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Korea University Guro Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "na"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Inje university Sanggye Paik Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease: Multicenter, Open-label, Parallel, Randomized Study", 
        "overall_contact": {
            "last_name": "Kim", 
            "phone": "+82 2 768 9422"
        }, 
        "overall_official": {
            "affiliation": "Korea University Guro Hospital", 
            "last_name": "Seongbeom Koh, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluate The total and each category score of K-NMSS", 
            "measure": "K-NMSS", 
            "safety_issue": "No", 
            "time_frame": "24 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01673724"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluate the Improvement of the depression refering to the total score of K-MADRS", 
                "measure": "K-MADRS", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Evaluate the improvement of UPDRS I/II/III", 
                "measure": "UPDRS I/II/III", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Evaluate the improvement of Patient's QOL", 
                "measure": "K-PDQ39", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }
        ], 
        "source": "Sandoz Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sandoz Korea", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}